For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Edinburgh

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Type
D - Journal article
Title of journal
The New England Journal of Medicine
Article number
-
Volume number
365
Issue number
26
First page of article
2484
ISSN of journal
0028-4793
Year of publication
2011
Number of additional authors
26
Additional information

The author made a substantial contribution to the conception and design of the study; to the organisation of the conduct of the study; to carrying out the study (including acquisition of study data); to analysis and interpretation of study data; helped draft the output and helped critique the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
A - The Institute for Genetics & Molecular Medicine
Citation count
218
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-